Platform companies — firms that work to validate an entire approach to drug discovery rather than just advance a lead therapeutic asset — are back in vogue. Just ask Flagship Pioneering. Flush from its success with the mRNA pioneer Moderna Therapeutics, the venture capital company has founded and backed >40 firms that are creating and applying novel technological and biological drug discovery strategies.
Enjoying our latest content?
Log in or create an account to continue
- Access the most recent journalism from Nature's award-winning team
- Explore the latest features & opinion covering groundbreaking research
or
Interviewed by Asher Mullard
Questions and answers have been edited for length and clarity.
